GGHCX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

GGHCX Analyst Rating

Strong Buy
86ConsensusRatings
81 Buy
5 Hold
0 Sell
Based on the consensus analyst ratings on 86 stocks held in GGHCX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GGHCX Analyst Price Target

Average Price Target

$47.06
Based on 86 Wall Street analysts offering 12 month price targets to Invesco Global Health Care Fund Cl A holdings in the last 3 months. The average price target is $47.06 with a high forecast of $53.27 and a low forecast of $39.79. The average price target represents a 11.05% change from the last price of $42.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"31":"$31","54":"$54","36.75":"$36.8","42.5":"$42.5","48.25":"$48.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":53.265,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$53.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":47.064,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$47.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":39.787,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$39.79</span>\n  </div></div>","useHTML":true}}],"tickPositions":[31,36.75,42.5,48.25,54],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"Feb<br/>2024","9":"May<br/>2024","12":"Aug<br/>2024","25":"Aug<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.1,42.03576923076923,42.971538461538465,43.9073076923077,44.84307692307692,45.77884615384615,46.714615384615385,47.65038461538462,48.58615384615385,49.52192307692307,50.45769230769231,51.39346153846154,52.32923076923077,{"y":53.265,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.1,41.55876923076923,42.017538461538464,42.47630769230769,42.93507692307693,43.393846153846155,43.85261538461538,44.31138461538462,44.770153846153846,45.22892307692308,45.68769230769231,46.14646153846154,46.60523076923077,{"y":47.064,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,41.1,40.999,40.898,40.797000000000004,40.696,40.595,40.494,40.393,40.292,40.191,40.089999999999996,39.989,39.888,{"y":39.787,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.09,"date":1690848000000,"info":"<div>Price: <b>$35<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.2,"date":1693526400000,"info":"<div>Price: <b>$35<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.47,"date":1696204800000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.64,"date":1698796800000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.55,"date":1701388800000,"info":"<div>Price: <b>$35<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.13,"date":1704153600000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.54,"date":1706745600000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":39.09,"date":1709251200000,"info":"<div>Price: <b>$39<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":39.24,"date":1711929600000,"info":"<div>Price: <b>$39<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.29,"date":1714521600000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":39.72,"date":1717372800000,"info":"<div>Price: <b>$40<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.3,"date":1719792000000,"info":"<div>Price: <b>$40<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":41.1,"date":1722470400000,"info":"<div>Price: <b>$41<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$53.27Average Price Target$47.06Lowest Price Target$39.79
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

GGHCX Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Kyverna Therapeutics, Inc.
3 Buy
1 Hold
0 Sell
Strong Buy
$26.67
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Scholar Rock Holding
6 Buy
0 Hold
0 Sell
Strong Buy
$28.75
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Tarsus Pharmaceuticals, Inc.
4 Buy
0 Hold
0 Sell
Strong Buy
$63.33
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Bridgebio Pharma
13 Buy
1 Hold
0 Sell
Strong Buy
$49.33
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Viking Therapeutics
10 Buy
0 Hold
0 Sell
Strong Buy
$113.22

GGHCX Stocks With Highest Downside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Halozyme Therapeutics
7 Buy
3 Hold
0 Sell
Moderate Buy
$60.33
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Hca Healthcare
13 Buy
4 Hold
0 Sell
Strong Buy
$379.80
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Regeneron Pharmaceuticals
18 Buy
2 Hold
0 Sell
Strong Buy
$1,175.84
xxxxxxxxxxxxxxxxxxxxxxxxxxx
AstraZeneca plc
11 Buy
4 Hold
1 Sell
Moderate Buy
$12,883.23
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Abbvie
11 Buy
5 Hold
0 Sell
Moderate Buy
$196.31

GGHCX Mutual Fund FAQ

What is GGHCX’s average 12-month price target, according to analysts?
Based on analyst ratings, Invesco Global Health Care Fund Cl A’s 12-month average price target is $47.06.
    What is GGHCX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GGHCX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is GGHCX a Buy, Sell or Hold?
        Invesco Global Health Care Fund Cl A has a consensus rating of Strong Buy which is based on 81 buy ratings, 5 hold ratings and 0 sell ratings.
          What is Invesco Global Health Care Fund Cl A’s price target?
          The average price target for Invesco Global Health Care Fund Cl A is $47.06. This is based on 86 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $53.27 ,the lowest forecast is $39.79. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Invesco Global Health Care Fund Cl A?
            Invesco Global Health Care Fund Cl A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 86 Wall Streets Analysts.
              How can I buy shares of GGHCX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis